Bismuth Subsalicylate Coagulopathy in a Patient with Chronic Liver Disease

Bioactive Bismuth Compounds: Is Their Toxicity a Barrier to Therapeutic Use?

Bismuth compounds are considered relatively non-toxic, with their low solubility in aqueous solutions (e.g., biological fluids) being the major contributing factor to this property. Bismuth derivatives are widely used for the treatment of peptic ulcers, functional dyspepsia, and chronic gastritis. Moreover, the properties of bismuth compounds have also been extensively explored in two main fields of action: antimicrobial and anticancer. Despite the clinical interest of bismuth-based drugs, several side effects have also been reported. In fact, excessive acute ingestion of bismuth, or abuse for an extended period of time, can lead to toxicity. However, evidence has demonstrated that the discontinuation of these compounds usually reverses their toxic effects. Notwithstanding, the continuously growing use of bismuth products suggests that it is indeed part of our environment and our daily lives, which urges a more in-depth review and investigation into its possible undesired activities. Therefore, this review aims to update the pharmaco-toxicological properties of bismuth compounds. A special focus will be given to in vitro, in vivo, and clinical studies exploring their toxicity.

Facile Fabrication of BiF3: Ln (Ln = Gd, Yb, Er)@PVP Nanoparticles for High-Efficiency Computed Tomography Imaging

X-ray computed tomography (CT) has been widely used in clinical practice, and contrast agents such as Iohexol are often used to enhance the contrast of CT imaging between normal and diseased tissue. However, such contrast agents can have some toxicity. Thus, new CT contrast agents are urgently needed. Owing to the high atomic number (Z = 83), low cost, good biological safety, and great X-ray attenuation property (5.74 cm² kg^-1 at 100 keV), bismuth has gained great interest from researchers in the field of nano-sized CT contrast agents. Here, we synthesized BiF₃: Ln@PVP nanoparticles (NPs) with an average particle size of about 380 nm. After coating them with polyvinylpyrrolidone (PVP), the BiF₃: Ln@PVP NPs possessed good stability and great biocompatibility. Meanwhile, compared with the clinical contrast agent Iohexol, BiF₃: Ln@PVP NPs showed superior in vitro CT imaging contrast. Subsequently, after in situ injection with BiF₃: Ln@PVP NPs, the CT value of the tumor site after the injection was significantly higher than that before the injection (the CT value of the pre-injection and post-injection was 48.9 HU and 194.58 HU, respectively). The morphology of the gastrointestinal (GI) tract can be clearly observed over time after oral administration of BiF₃: Ln@PVP NPs. Finally, the BiF₃: Ln@PVP NPs were completely discharged from the GI tract of mice within 48 h of oral administration with no obvious damage to the GI tract. In summary, our easily synthesized BiF₃: Ln@PVP NPs can be used as a potential clinical contrast agent and may have broad application prospects in CT imaging.

Versatile Colorimetric Chemosensor Based on Bis(rhodamine) B Hydrazone for Rapid Detection of Multi-Analytes (Fe3+, Bi3+, Cu2+, and Hg2+) in Aqueous Media

A new bis(rhodamine) B hydrazone L, bearing two rhodamine chromophores, has been designed and synthesised in 70% yield. The chemical structure of the new ligand L was characterised using different spectroscopic techniques. The receptor L was utilised for rapid ‘naked eye’ detection of Fe3+, Bi3+, Cu2+, and Hg2+ in THF–H2O (1:1, v/v) by displaying significant colour changes. The mechanism of detection of metal ions was based on the ring-opening of the spirolactam rings of L upon recognition. UV/Vis spectrometry was employed to investigate L–metal ion interactions in THF–H2O (1:1, v/v). The stoichiometries of the complexes were determined using Job’s method, which revealed 1:2L–metal ion stoichiometries in the case of L–(Fe3+/Bi3+/Hg2+) complexes, while a 1:1L–metal ion stoichiometry was recognised for the L–Cu2+ complex. 1H NMR spectroscopy was applied to study the L–metal ion interactions in DMSO-d6 and results are presented.